OBIO logo

OBIO

Profile

Full Name

Orchestra BioMed Holdings, Inc.

Ticker Symbol

OBIO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 4, 2020

Indexes

Not included

Website

http://orchestrabiomed.com

Employees

70

Key Details

Price

$2.80(-6.04%)

Market cap

$107.28M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.64M(-4.42% YoY)

Annual EPS

-$1.66(-12.16% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.80
OBIO price is $2.80

30-Day Relative Volume

0.65
OBIO 30-day relative volume is 0.65

Price Performance

Price Most recent change

-6.04%
OBIO price was down -6.04% on Apr 14, 2025

Price YTD change

-30%
OBIO price is down -30% since January 1st

Price 1-year change

-42.15%
OBIO price is down -42.15% year-on-year

Price 3-year change

-71.8%
OBIO price is down -71.8% over the past 3 years

Price Range

Price All-time high

$23.39
OBIO price is currently -88.03% below its historical high of $23.39

Price 3-year low

$2.49
OBIO price is currently +12.45% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$107.28M
OBIO market capitalization is $107.28 million

Market cap 3-year change

-
OBIO market capitalization 3-year change is unknown

Market cap All-time high

$704.02M
OBIO market capitalization is currently -84.76% below its historical high of $704.02 million

Market cap sector rank

49.42%
OBIO market capitalization is higher than 49.42% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+7.06%
OBIO shares outstanding is up +7.06% year-on-year

Shares Outstanding 3-Year Change

-
OBIO shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.60
OBIO beta is 1.60

200-day SMA

$5.53
OBIO price is currently -49.36% below its 200-day simple moving average

50-day SMA

$4.39
OBIO price is currently -36.24% below its 50-day simple moving average

RSI

35.69
OBIO 14-day relative strength index is 35.69

Volume

0.65
OBIO 30-day relative volume is 0.65

ATR

$0.47
OBIO average true range is $0.47

10-day Historical Volatility

184.44%
OBIO 10-day historical volatility is 184.44%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.64M
OBIO annual revenue is $2.64 million

Revenue Analysts estimate

$2.58M
OBIO annual revenue is currently +2.26% higher than the consensus analysts' forecast

Revenue 1-year change

-4.42%
OBIO annual revenue is down -4.42% year-on-year

Revenue Sector rank

17.02%
OBIO annual revenue is higher than 17.02% of companies in Healthcare sector

EPS

EPS

-$1.66
OBIO annual earnings per share is -$1.66

EPS Analysts estimate

-$2.02
OBIO annual earnings per share is currently -17.96% lower than the consensus analysts' forecast

EPS 1-year change

-12.16%
OBIO annual earnings per share is down -12.16% year-on-year

EPS Sector rank

42.35%
OBIO annual earnings per share is higher than 42.35% of companies in Healthcare sector

Profit

Gross profit

$2.43M
OBIO annual gross profit is $2.43 million

Gross margin

92.27%
OBIO annual gross profit margin is 92.27%

Operating profit

-$64.30M
OBIO annual operating income is -$64.30 million

Operating margin

-2437.49%
OBIO annual operating profit margin is -2437.49%

Net income

-$61.02M
OBIO annual net profit is -$61.02 million

Net margin

-2313.27%
OBIO annual net profit margin is -2313.27%

Expenses

Total expenses

$66.94M
OBIO annual total expenses is $66.94 million

Operating expenses

$66.73M
OBIO annual total operating expenses is $66.73 million

Cost of goods sold

$204.00K
OBIO annual cost of goods sold is $204.00 thousand

Selling, general & administrative expenses

$23.93M
OBIO annual SGA is $23.93 million

Depreciation and amortization

$308.00K
OBIO annual depreciation & amortization is $308.00 thousand

Interest expense

-
OBIO annual interest expense value is unknown

Income tax

-
OBIO annual income tax value is unknown

EBIT & EBITDA

EBIT

-$64.30M
OBIO annual earnings before interest & taxes is -$64.30 million

EBITDA

-$63.99M
OBIO annual EBITDA is -$63.99 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$76.17M
OBIO annual total assets is $76.17 million

Non current assets

$7.00M
OBIO annual long term assets is $7.00 million

Current assets

$69.17M
OBIO annual total current assets is $69.17 million

Cash and cash equivalents

$22.26M
OBIO annual cash & cash equivalents is $22.26 million

Accounts receivable

$92.00K
OBIO annual accounts receivable is $92.00 thousand

Inventory

$173.00K
OBIO annual inventory is $173.00 thousand

Liabilities

Total liabilities

$43.22M
OBIO annual total liabilities is $43.22 million

Long term liabilities

$27.01M
OBIO annual total long term liabilities is $27.01 million

Current liabilities

$16.21M
OBIO annual total current liabilities is $16.21 million

Accounts payable

$5.13M
OBIO annual accounts payable is $5.13 million

Debt

Total debt

$16.53M
OBIO annual total debt is $16.53 million

Total debt 1-year change

+879.79%
OBIO annual total debt is up +879.79% year-on-year

Long term debt

$15.98M
OBIO annual long term debt is $15.98 million

Short term debt

$550.00K
OBIO annual short term debt is $550.00 thousand

Equity & Capital

Shareholders equity

$32.96M
OBIO annual stockholders equity is $32.96 million

Book value

$32.96M
OBIO annual book value is $32.96 million

Retained earnings

-$309.88M
OBIO annual retained earnings is -$309.88 million

Working capital

$52.96M
OBIO annual working capital is $52.96 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$50.56M
OBIO annual cash flow from operations is -$50.56 million

Cash from operations 1-year change

-9.61%
OBIO annual cash flow from operations is down -9.61% year-on-year

Cash from investing

$13.09M
OBIO annual cash flow from investing activities is $13.09 million

Cash from investing 1-year change

+22.48%
OBIO annual cash flow from investing activities is up +22.48% year-on-year

Cash from financing

$29.17M
OBIO annual cash flow from financing activities is $29.17 million

Cash from financing 1-year change

-36.88%
OBIO annual cash flow from financing activities is down -36.88% year-on-year

CAPEX

CAPEX

$289.00K
OBIO annual capital expenditures is $289.00 thousand

CAPEX 1-year change

+270.51%
OBIO annual capital expenditures is up +270.51% year-on-year

Free Cash Flow

Free cash flow

-$50.85M
OBIO annual free cash flow is -$50.85 million

Free cash flow 1-year change

-10.05%
OBIO annual free cash flow is down -10.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

92.27%
OBIO annual gross profit margin is 92.27%

Operating margin

-2437.49%
OBIO annual operating profit margin is -2437.49%

Net margin

-2313.27%
OBIO annual net profit margin is -2313.27%

ROA & ROE

ROA

-71.21%
OBIO annual return on assets is -71.21%

ROE

-120.84%
OBIO annual return on equity is -120.84%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OBIO price to earnings ratio value is unknown

PE ratio Sector rank

-
OBIO price to earnings ratio is unknown

PB Ratio

PB ratio

3.25
OBIO price to book ratio is 3.25

PB ratio Sector rank

73.83%
OBIO price to book ratio is higher than 73.83% of companies in Healthcare sector

PS Ratio

PS ratio

40.67
OBIO price to sales ratio is 40.67

PS ratio Sector rank

91.28%
OBIO price to sales ratio is higher than 91.28% of companies in Healthcare sector

Enterprise value

Enterprise value

$101.54M
OBIO enterprise value is $101.54 million

Enterprise value Sector rank

50.58%
OBIO enterprise value is higher than 50.58% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.59
OBIO EV/EBITDA is -1.59

EV/EBITDA Sector rank

36.35%
OBIO EV/EBITDA is higher than 36.35% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.27
OBIO annual current ratio is 4.27

Quick ratio

4.26
OBIO annual quick ratio is 4.26

Leverage

Debt to equity

0.43
OBIO annual debt to equity ratio is 0.43

Interest coverage ratio

-
OBIO annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

2
OBIO piotroski f-score is 2

Altman Z-Score

-6.12
OBIO altman z-score is -6.12

Analyst ratings

Recent major analysts updates

Apr 4, 25 HC Wainwright & Co.
Buy
Apr 1, 25 Chardan Capital
Buy
Mar 20, 25 BTIG
Buy
Mar 10, 25 HC Wainwright & Co.
Buy
Jan 2, 25 Barclays
Overweight
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Chardan Capital
Buy
Aug 22, 24 HC Wainwright & Co.
Buy
Jul 25, 24 B. Riley Securities
Buy
Jun 12, 24 Chardan Capital
Buy

Institutional Ownership

Similar stocks

LUCD logo
Lucid Diagnostics (LUCD)
Neumora Therapeutics (NMRA)
FATE logo
Fate Therapeutics (FATE)
CSBR logo
Champions Oncology (CSBR)
IRWD logo
Ironwood Pharmaceuticals (IRWD)
ENTA logo
Enanta Pharmaceuticals (ENTA)
INFU logo
InfuSystem Holdings (INFU)
EDIT logo
Editas Medicine (EDIT)
TIL logo
Instil Bio (TIL)
  • What is the ticker symbol for Orchestra BioMed Holdings?
  • Does Orchestra BioMed Holdings pay dividends?
  • What sector is Orchestra BioMed Holdings in?
  • What industry is Orchestra BioMed Holdings in?
  • What country is Orchestra BioMed Holdings based in?
  • When did Orchestra BioMed Holdings go public?
  • Is Orchestra BioMed Holdings in the S&P 500?
  • Is Orchestra BioMed Holdings in the NASDAQ 100?
  • Is Orchestra BioMed Holdings in the Dow Jones?
  • When was Orchestra BioMed Holdings's last earnings report?
  • When does Orchestra BioMed Holdings report earnings?
  • Should I buy Orchestra BioMed Holdings stock now?

What is the ticker symbol for Orchestra BioMed Holdings?

The ticker symbol for Orchestra BioMed Holdings is NASDAQ:OBIO

Does Orchestra BioMed Holdings pay dividends?

No, Orchestra BioMed Holdings does not pay dividends

What sector is Orchestra BioMed Holdings in?

Orchestra BioMed Holdings is in the Healthcare sector

What industry is Orchestra BioMed Holdings in?

Orchestra BioMed Holdings is in the Biotechnology industry

What country is Orchestra BioMed Holdings based in?

Orchestra BioMed Holdings is headquartered in United States

When did Orchestra BioMed Holdings go public?

Orchestra BioMed Holdings's initial public offering (IPO) was on August 4, 2020

Is Orchestra BioMed Holdings in the S&P 500?

No, Orchestra BioMed Holdings is not included in the S&P 500 index

Is Orchestra BioMed Holdings in the NASDAQ 100?

No, Orchestra BioMed Holdings is not included in the NASDAQ 100 index

Is Orchestra BioMed Holdings in the Dow Jones?

No, Orchestra BioMed Holdings is not included in the Dow Jones index

When was Orchestra BioMed Holdings's last earnings report?

Orchestra BioMed Holdings's most recent earnings report was on Mar 31, 2025

When does Orchestra BioMed Holdings report earnings?

The next expected earnings date for Orchestra BioMed Holdings is May 13, 2025

Should I buy Orchestra BioMed Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page